| pubmed-article:19911168 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0024554 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0010132 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:19911168 | lifeskim:mentions | umls-concept:C1512045 | lld:lifeskim |
| pubmed-article:19911168 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19911168 | pubmed:dateCreated | 2010-1-21 | lld:pubmed |
| pubmed-article:19911168 | pubmed:abstractText | Corticotropin-releasing factor receptor type 1 (CRF(1)) antagonists have been proposed as therapeutic agents in the treatment of mood and anxiety disorders although clinical evidence supporting their development and understanding of a dose-response relationship has been lacking. | lld:pubmed |
| pubmed-article:19911168 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19911168 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19911168 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19911168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19911168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19911168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19911168 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19911168 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19911168 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19911168 | pubmed:issn | 1432-2072 | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:StecklerThoma... | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:BrownTerryT | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:SchmidtMark... | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:MannaertErikE | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:de HoonJanJ | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:AndrewsRandol... | lld:pubmed |
| pubmed-article:19911168 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:19911168 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19911168 | pubmed:volume | 208 | lld:pubmed |
| pubmed-article:19911168 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19911168 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19911168 | pubmed:pagination | 109-19 | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:meshHeading | pubmed-meshheading:19911168... | lld:pubmed |
| pubmed-article:19911168 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19911168 | pubmed:articleTitle | Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects. | lld:pubmed |
| pubmed-article:19911168 | pubmed:affiliation | Johnson & Johnson Pharmaceutical Research and Development, Turnhoutseweg 30, 2340, Beerse, Belgium. mschmid4@its.jnj.com | lld:pubmed |
| pubmed-article:19911168 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19911168 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19911168 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
